Used primarily in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds. Its structure supports the development of drugs targeting central nervous system disorders, including anxiety and depression, due to its affinity for neurotransmitter receptors such as serotonin and dopamine receptors. Also explored in the design of novel antipsychotic and antidepressant agents. The compound's heterocyclic framework enhances metabolic stability and bioavailability in new drug candidates. Additionally, it serves as a building block in medicinal chemistry for creating libraries of piperazine-based molecules for high-throughput screening.